Both exosome levels and mortalin expression within tumor cell exosomes were higher than in healthy donors, except in pancreatic carcinoma, where exosomes were elevated but mortalin expression was not significantly different from healthy donors. This evidence concerns the gene HSPA9 and exocrine pancreatic carcinoma.